ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ АНТИСМЫСЛОВОЙ ГЕННОЙ ТЕРАПИИ ПРИ ТРАНСПЛАНТАЦИИ ОРГАНОВ


https://doi.org/10.15825/1995-1191-2013-1-106-117

Полный текст:


Аннотация

Главной проблемой трансплантологии остается дефицит донорских органов. Использование для транс- плантации органов, полученных от доноров с расширенными критериями, позволяет расширить донор- ский пул, увеличивая доступность трансплантации нуждающимся в ней пациентам с терминальными стадиями болезней внутренних органов. Основным препятствием к широкому использованию доноров с расширенными критериями является ишемическое повреждение, следующая за ним ишемически- реперфузионная травма органов, активация сценариев программируемой клеточной гибели, приводящие к снижению функционального резерва трансплантатов, а зачастую к развитию тяжелых осложнений в послеоперационном периоде. Применение антисмысловой генной терапии при трансплантации может послужить терапевтическим инструментом, позволяющим влиять на трансплантат на всех этапах работы с ним, улучшая его качество, и следовательно, результат трансплантации. 


Об авторах

О. Н. Резник
ГБОУ ВПО «СПбГМУ им. акад. И.П. Павлова», Санкт-Петербург


А. Е. Скворцов
ГБОУ ВПО «СПбГМУ им. акад. И.П. Павлова», Санкт-Петербург


Д. О. Кузьмин
ГБОУ ВПО «СПбГМУ им. акад. И.П. Павлова», Санкт-Петербург


А. П. Тутин
ГБОУ ВПО «СПбГМУ им. акад. И.П. Павлова», Санкт-Петербург


А. О. Резник
ГБОУ ВПО «СПбГМУ им. акад. И.П. Павлова», Санкт-Петербург


Список литературы

1. СПИСОК ЛИТЕРАТУРЫ

2. Скулачев В.П. Явление запрограммированной смер- ти. Митохондрии, клетки и органы: роль активных форм кислорода // Соросовский образовательный журнал. 2001. T. 7. No 6. С. 1–10.

3. Иванов К.П. Роль лейкоцитов в динамике микро- циркуляции в норме и при патологии // Вестник Рос- сийской Академии медицинских наук. 2004. No 4. С. 3–13.

4. Allen B., Ilbawi M. Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery // Perfusion. 2001. Vol. 16. P. 19–29.

5. Anversa P., Cheng W., Liu Y., Leri A. et al. Apoptosis and myocardial infarction // Basic. Res. Cardiol.1998. Vol. 93 (3). P. 8–12.

6. Baranova A.V., Marakhonov A.V., Skoblov M.Yu. siRNA characteristics and properties of it’s nonviral delivery systems // Molecular Biology. 2012. Vol. 46 (3). P. 371– 386.

7. Baranova A.V., Marakhonov A.V., Skoblov M.Yu. Types of non-viral delivery systems of small interfering RNA // Molecular Biology. 2012. Vol. 46 (3). P. 387–401.

8. Barnhart B.C., Lee J.C., Alappat E.C. et al. The death effector domain protein family // Oncogene. 2003. Vol. 22 (53). P. 8634–8644.

9. Blydt-Hansen T.D. et al. Gene transfer-induced local HO-1 overexpression protects rat kidney transplants from IRI // J. Am. Soc. Nephrol. 2003. Vol. 14. P. 745– 754.

10. Braasch D.A., Paroo Z., Constantinescu A. Biodistribu- tion of phosphodiester and phosphorothioate siRNA // Bioorg. Med. Chem. Lett. 2004. Vol. 14 (5). P. 1139– 1143.

11. Cantarovich F., Heguilén R., Filho M.A. et al. An inter- national opinion poll of well-educated people regarding awareness and feelings about organ donation for trans- plantation // Transpl. Int. 2007. Vol. 20 (6). P. 512–518.

12. Cecka J.M. Donors without a heartbeat // N. Engl. J. Med. 2002. Vol. 347 (4). P. 281–283.

13. Celi A., Pellegrini G., Lorenzet R., De Blasi A., et al. P-selectin induces the expression of tissue factor on monocytes // Proc. Natl. Acad. Sci USA. 1994. Vol. 91 (19). P. 8767–8771.

14. Celotto A.M., Graveley B.R. Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing // RNA. 2002. Vol. 8 (6). P. 718–724.

15. Cho W.Y, Terasaki P.I., Cecka J.I. Transplantation of kidneys from donors whose hearts stopped beating // N. Engl. J. Med. 1998. Vol. 338. P. 221–225.

16. Choy J.C., Cruz R.P., Kerjner A. et al. Granzyme B in- duces endothelial cell apoptosis and contributes to the development of transplant vascular disease // Am. J. Transplant. 2005.Vol. 5 (3). P. 494–499.

17. Clark P.A., Drain M., Malone M.P. Addressing patients’ emotional and spiritual needs // Jt Comm. J. Qual. Saf. 2003. Vol. 29 (12). P. 659–670.

18. Contreras J.L., Vilatoba M., Eckstein C. et al. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/ reperfusion injury to the liver in mice // Surgery. 2004. Vol. 136 (2). P. 390–400.

19. Cypel M., de Perrot M., Keshavjee S. et al. Normother- mic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation // Am. J. Transplant. 2009. Vol. 9 (10). P. 2262–2269.

20. Darwish R.S. Regulatory mechanisms of apoptosis in regularly dividing cells // Cell Health and Cytoskeleton. 2010. Vol. 2. P. 59–68.

21. David K.K., Sasaki M., Yu S.W. et al. EndoG is dispensable in embryogenesis and apoptosis // Cell. Death. Differ. 2006. Vol. 13 (7). P. 1147–1155.

22. De Vries A.J., Gu Y.J., Post W.J. et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies // Perfusion. 2003. Vol. 18. P. 31–38.

23. de Vries D.K., Lindeman J.H., Tsikas D. et al. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft // Am. J. Transplant. 2009. Vol. 9 (7). P. 1574–1584.

24. Delmonico F.L., Harmon W.E. Use of expanded criteria donors in solid organ transplantation // Curr. Opinion in Organ Transpl. 2000. Vol. 5 (3). P. 227–231.

25. Delmonico F.L., Dominguez-Gil B., Matesanz R., Noel L. A call for government accountability to achieve national self-sufficiency in organ donation and transplantation // Lancet. 2011. Vol. 378. P. 1414–1418.

26. Diebold S.S., Kaisho T., Hemmi H. Innate antiviral re- sponses by means of TLR7-mediated recognition of single-stranded RNA // Science. 2004. Vol. 303 (5663). P. 1529–1531.

27. Djamali A., Vidyasagar A., Adulla M. et al. Nox-2 is a modulator of fibrogenensis in kidney allografts // Am. J. Transplant. 2009. Vol. 9. P. 74–82.

28. Doevendans P.A., Cramer M.J., Lips D.J. et al. Role of apoptosis in reperfusion injury // Cardiovasc. Res. 2004. Vol. 61 (3). P. 414–426.

29. Dolęgowska B., Blogowski W., Domanski L. Clinical evidence of the association between serum preoperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function // J. Am. Coll Surg. 2010. Vol. No 211 (5). P. 587–595.

30. Dumont E.A., Hofstra L., Liem I.H., Boersma H.H. Vi- sualisation of cell death in vivo in patients with acute myocardial infarction // Lancet. 2000. Vol. 356 (9225). P. 209–212.

31. Elbashir S.M., Bechert K., Tuschl T. et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs // J. Cell Sci. 2001. Vol. 114 (24). P. 4557–4565.

32. Favreau F., Thuillier R., Cau J. et al. Antithrombin the- rapy during warm ischemia and cold preservation pre- vents chronic kidney graft fibrosis in a DCD model // Am. J. Transplant. 2010. Vol. 10. P. 30–39.

33. Fattal E., Bochot A. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA // Adv. Drug. Deliv. Rev. 2006. Vol. 58 (11). P. 1203–1223.

34. Fernandes E.S., Courade J.P., Keeble J.E. et al. Tumour necrosis factor alpha mediates transient receptor poten- tial vanilloid 1-dependent bilateral thermal hyperalgesia with distinct peripheral roles of interleukin-1beta, protein kinase C and cyclooxygenase-2 signalling // Pain. 2009. Vol. 142 (3). P. 264–274.

35. Flavell R.A., Alexopoulou L., Holt A.C. et al. Recog- nition of double-stranded RNA and activation of NF- kappaB by Toll-like receptor 3 // Nature. 2001. Vol. 413 (6857). P. 732–738.

36. Fondevila C. et al. In vivo normothermic recirculation: an update // Curr. Op. Organ Transplant. 2010. Vol. 15. P. 173–176.

37. Friend P.J. et al. Ex vivo normothermic liver perfusion: an update // Curr. Op. Organ. Transplant. 2010. Vol. 15. P. 167–172.

38. Furuichi K., Yokoyama H., Wada T. Chemokines in renal fibrosis // Contrib. Nephrol. 2003. Vol. 139. P. 66–89.

39. Galluzzi L., Kroemer G., Vandenabeele P. et al. Classi- fication of cell death: recommendations of the Nomen- clature Committee on Cell Death 2009 // Cell. Death. Differ. 2009. Vol. 16 (1). P. 3–11.

40. Galluzzi L., Maiuri M.C., Vitale I. et al. Cell death modali- ties: classification and pathophysiological implications // Cell. Death. Differ. 2007. Vol. 14 (7). P. 1237–1243.

41. Galluzzi L., Vitale L., Abrams J.M. et al. Molecular de- finitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012 // Cell. Death. and Differentiation. 2011. Vol. 19. P. 107–120.

42. Garcia C.E., Bramhall S., Mirza D.F. Use of marginal donors // Curr. Opinion in Organ Transpl. 2000. Vol. 5. P. 50–56.

43. Goldstein P., Kroemer G. Cell death by necrosis: towards a molecular definition // Trends. Biochem. Sci. 2007. Vol. 32 (1). P. 37–43.

44. Gottlieb R.A., Burleson K.O., Kloner R.A. et al. Reperfu- sion injury induces apoptosis in rabbit cardiomyocytes // J. Clin. Invest. 1994. Vol. 94 (4). P. 1621–1628.

45. Granger D.N., Senchenkova E. Leukocyte-Endothelial cell adhesion // Inflammation and the Microcirculation / San Rafael (CA): Morgan & Claypool Life Sciences. 2010. P. 29–38.

46. Graper L. Eine neue Anschauug uber physiologische- Zellausschaltung // Arch. Zeliforsch. 1914. No 12. P. 373–394.

47. Hebert M., Pallet N., Dieude M. et al. The Molecular Legacy of Apoptosis in Transplantation // Am. J. Trans- plant. 2012. Vol. 12. P. 1378–1384.

48. Hitomi J., Christofferson D.E. et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway // Cell. 2008. Vol. 135 (7). P. 1311–1323.

49. Hoogland E.R., van Heurn L.W., Snoeijs M.G. DCD kidney transplantation results and measures to improve outcome // Curr. Op. Organ Transplant. 2010. Vol. 15. P. 177–182.

50. Hosgood S.A. et al. Normothermic kidney preservation // Curr. Op. Organ Transplant. 2011. Vol. 16. P. 169–173.

51. Hotchkiss R.S., Strasser A., McDunn J.E. Cell Death // N. Engl. J. Med. 2009. Vol. 361 (16). P. 1570–1583.

52. Huang D.C., Adams J.M., Cory S. The conserved N-ter-

53. minal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4 // EMBO J. 1998. Vol. 17 (4). P. 1029–1039.

54. Jagtap P., Degterev A., Huang Z. et al. Chemical inhibi- tor of nonapoptotic cell death with therapeutic potential for ischemic brain injury // Nat. Chem. Biol. 2005. Vol. 1 (2). P. 112–119.

55. Childress J.F., Liverman C.T. Organ Donation: Oppor- tunities for Action // Institute of Medicine (U.S.). Com- mittee on Increasing Rates of Organ Donation. 2006. P. 6–7.

56. Jang H.R., Ko G.J., Wasowska B.A. et al. The interaction between ischemia-reperfusion and immune responses in the kidney // J. Mol. Med. 2009. Vol. 87 (9). P. 859–864.

57. Kauffman M.H., Bennett L.E., McBride M.A. et al. The expanded donor // Transplant. Rev. 1997. Vol. 11. P. 165–190.

58. Kim J., Seok Y.M., Jung K.J., Park K.M. Reactive oxy- gen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice // Am. J. Physiol. 2009. Vol. 297. P. F461–F470.

59. Koo D.H., Fuggle S.V. Impact of ischemia/reperfusion injury and early inflammatory responses in kidney trans- plantation // Transplantation Rewiews. 2000. Vol. 14 (2). P. 210–224.

60. Koo D.H., Fuggle S.V. The role of mitochondria in ische- mia/reperfusion injury // Transplantation. 2002. Vol. 27. Vol. 73 (4). P. 493–499.

61. Kootstra G. Asystolic or non-heartbeating donor // Transplantation. 1997. Vol. 63 (7). P. 917–921.

62. Kroemer G., Galluzzi L. Necroptosis: a specialized pa- thway of programmed necrosis // Cell. 2008. Vol. 135 (7). P. 1161–1163.

63. Kroemer G., Green D.R., Ferguson T. et al. Immunogenic and tolerogenic cell death // Nat. Rev. Immunol. 2009. Vol. 9 (5). P. 353–363.

64. Kupiec-Weglinski J.W., Zhai Y., Busuttil R.W. Liver ischemia and reperfusion injury: new insights into me- chanisms of innate-adaptive immune-mediated tissue inflammation // Am. J. Transplant. 2011. Vol. 11 (8). P. 11563–11569.

65. Kwon Y.J. Efficient and targeted delivery of siRNA in vivo // FEBS J. 2010. Vol. 277. P. 4814–4827.

66. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation // Transplantation. 2005. Vol. 79. P. 505–514.

67. Ley K., Laudanna C., Cybulsky M.I. et al. Getting to the site of inflammation: the leukocyte adhesion cascade up- dated // Nature. 2007. Vol. 7. P. 678–689.

68. Linfert D., Chowdhry T., Rabb H. Lymphocytes and ischemia-reperfusion injury // Transplant Rev. 2009. Vol. 23 (1). P. 1–10.

69. Lipták P., Kemény E., Morvay Z. et al. Peritubular capil- lary damage in acute humoral rejection: an ultrastructu- ral study on human renal allografts // Am. J. Transplant. 2005. Vol. 5 (12). P. 2870–2876.

70. Lisman T. Activation of coagulation by living donor kidney transplant early after reperfusion // Am. J. Trans- plant. 2010. Vol. 10. P. 434.

71. Luque Gálvez P., Álvarez-Vijande R. Study of cell energy charge in experimental kidney transplant with different warm ischemia periods // Actas. Urol. Esp. 2008. Vol. 32 (1). P. 41–58.

72. Maltzman J.S., Haase V.H. Low oxygen stimulates the im- mune system // Kidney Int. 2008. Vol. 73 (7). P. 797–799.

73. Mello C.C., Grishok A., Tabara H. Genetic requirements for inheritance of RNAi in C. elegans // Science. 2000.

74. Vol. 287 (5462). P. 2494–2497.

75. Metzger R.A., Delmonico F.L., Feng S. et al. Expanded

76. criteria donors for kidney transplantation // Am. J. Trans-

77. plant. 2003. Vol. 3 (4). P. 114–125.

78. Min W., Jevnikar A.M., Chen G. et al. Targeted Gene

79. Ploeg R.J., Bouma H.R., Schuurs T.A. Signal transduc- tion pathways involved in brain death-induced renal in- jury // Am. J. Transplant. 2009. Vol. 9 (5). P. 989–997.

80. Leuvenink H.G., Ploeg R.J., Damman J. et al. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-re- perfusion injury // Am. J. Transplant. 2011. Vol. 11 (4). P. 660–669.

81. Leuvenink H.G., Ploeg R.J., Welmoet H. et al. Brain death induced injury // Curr. Op. 2011. Vol. 16 (2).

82. Reischl D., Zimmer A. Drug delivery of siRNA therapeu- tics: potentials and limits of nanosystems // Nanomed. Nanotechnol. Biol. Med. 2009. Vol. 5 (1). P. 8–20.

83. Rosengard B.R., Delmonico F.L., Kauffman H.M. et al. Increased transplanted organs from the use of a standar- dized donor management protocol // Am. J. Transplant. 2002. Vol. 2 (8). P. 761–768.

84. Reznik O., Skvortsov A., Moysyuk Y. et al. Kidney from uncontrolled donors after cardiac death with one H warm ischemic time: resuscitation by extracorporal normo- thermic abdominal perfusion «in situ» by leukocytes- free oxygenated blood // Clin. Transplant. 2010. DOI: 10.1111/j.1399-0012.2010.01333.x

85. Rosental R. Organ Donors: Deceased or alive? Quo Vadis? // Annals of Transplantation. 2006. Vol. 11 (3). P. 49–51.

86. Rowinski W., Kosieradzki M. Ischemia/reperfusion inju- ry in kidney transplantation: mechanisms and preventi- on // Transplant. Proc. 2008. Vol. 40 (10). P. 3279–3288.

87. Samankatiwat P., Samartzis I., Lertsithichai P. et al. Leu- cocyte depletion in cardiopulmonary bypass: a compari- son of four strategies // Perfusion. 2003. Vol. 18. P. 95–

88. Silencing of TLR4 Using Liposomal Nanoparticles for 105.

89. Preventing Liver Ischemia Reperfusion Injury // Am. J.

90. of Transplant. 2011. Vol. 11. P. 1835–1844.

91. Min W.P. et al. Novel Small Interfering RNA-Containing Solution Protecting Donor Organs in Heart Transplanta-

92. Sanchez-Fructuoso A.I., Prats D. et al. Non-heart bea- ting donors: experience from the Hospital Clinico of Ma- drid // J. Nephrol. 2003. Vol. 16 (3). P. 387–392.

93. Segura T., Tokatlian T. siRNA applications in nanomedi- cine // Nanomed. Nanobiotechnol. 2010. Vol. 2. P. 305–

94. tion // Circulation. 2009. Vol. 120. P. 1099–1107.

95. Min W.P. et al. Protection of Renal Ischemia Injury using 315.

96. Combination Gene Silencing of Complement 3 and Cas- pase 3 Genes // Transplantation. 2006. Vol. 82. P. 1781– 1786.

97. Moers C., Leuvenink H.G.D., Ploeg R.J. Non-heart bea- ting organ donation: overview and future perspectives // Transplant. International. 2007. Vol. 20 (7). P. 567–575.

98. Mone T.D. The business of organ procurement // Curr. Opin. Organ Transplant. 2002. Vol. 7. P. 60–64.

99. Nicholson M.L. et al. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys // Transplantation. 2011. Vol. 91 (5). P. 501–507.

100. Nicholson M.L., Yates P.J., Hosgood S.A. Leukocyte and platelet depletion improves blood flow and function in a renal transplant model // J. Surg. Res. 2012. Vol. No 172 (1). P. 159–164.

101. Novitzky D. Donor management: state of the art // Trans- plant Proc. 1997. Vol. 29 (8). P. 3773–3775.

102. Ollinger R., Pratschke J. Role of heme oxygenase-1 in transplantation // Transpl. Int. 2010. Vol. 23 (11). P. 1071–1081.

103. Sharpe C.C., Wang J.H., Hendry B.M. Silencing genes in the kidney: antisense or RNA interference? // Nephrol. Dial. Transplant. 2008. Vol. 23 (7). P. 2115–2118.

104. Simmons M.N., Schreiber M.J., Gill I.S. Surgical renal ischemia: a contemporary overview // J. Urol. 2008. Vol. 180 (1). P. 19–30.

105. Snoeijs M.G., Winkens B., Heemskerk M.B. et al. Kid- ney transplantation from donors after cardiac death: a 25-year experience // Transplantation. 2010. Vol. 90. P. 1106–1112

106. Sprague A.H., Khalil R.A. Inflammatory cytokines in va- scular dysfunction and vascular disease // Biochem Phar- macol. 2009. Vol. 78 (6). P. 539–552.

107. Steen S., Ingemansson R., Lindstedt S. et al. Compara- tive outcome of double lung transplantation using con- ventional donor lungs and non-acceptable donor lungs reconditioned ex vivo // Interact. Cardiovasc. Thorac. Surg. 2011. Vol. 12 (2). P. 162–165.

108. Stokman G., Qin Y., Racz Z. et al. Application of siRNA in targeting protein expression in kidney desease // Adv. Drug Deliv Rev. 2010. Vol. 62. P. 1378–1389.


Дополнительные файлы

Для цитирования: Резник О.Н., Скворцов А.Е., Кузьмин Д.О., Тутин А.П., Резник А.О. ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ АНТИСМЫСЛОВОЙ ГЕННОЙ ТЕРАПИИ ПРИ ТРАНСПЛАНТАЦИИ ОРГАНОВ. Вестник трансплантологии и искусственных органов. 2013;15(1):106-117. https://doi.org/10.15825/1995-1191-2013-1-106-117

For citation: Reznik O.N., Skvortsov A.E., Kuzmin D.O., Tutin A.P., Reznik A.O. PERSPECTIVES OF ANTISENSE GENE THERAPY IN ORGAN TRANSPLANTATION. Russian Journal of Transplantology and Artificial Organs. 2013;15(1):106-117. (In Russ.) https://doi.org/10.15825/1995-1191-2013-1-106-117

Просмотров: 658


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)
ISSN 2412-6160 (Online)